NICE approves Botox for migraine prophylaxis

Patients with chronic migraine can now be prescribed botulinum toxin type A (Botox) on the NHS, following a recommendation from NICE.

Botox is also licensed for the reduction of glabellar lines, hyperhidrosis and certain types of muscle spasm and spasticity | SCIENCE PHOTO LIBRARY
Botox is also licensed for the reduction of glabellar lines, hyperhidrosis and certain types of muscle spasm and spasticity | SCIENCE PHOTO LIBRARY
The product can be used in adults with chronic migraine, defined as headaches on at least 15 days per month of which at least 8 days are with migraine. Patients must have not responded to at least three prior pharmacological prophylaxis therapies and must be managed appropriately for medication overuse.

Treatment should be stopped if the response is inadequate after two treatment cycles, that is, if there is a less than 30% reduction in headache days per month, or if the patient’s condition has changed to episodic migraine (fewer than 15 headache days per month) for 3 consecutive months.

Botox is the only botulinum toxin product that is licensed for migraine prophylaxis.

Further details
NICE guidance on botulinum toxin for chronic migraine

Further information
View Botox drug record

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Antidiabetic Agents, Use in Renal Impairment

Antidiabetic Agents, Use in Renal Impairment

Dosing of diabetes drugs in patients with renal impairment.

Insulin Delivery Devices

Insulin Delivery Devices

Features and compatibility of insulin pens.

Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Blood Glucose Testing Strips and Meters

Blood Glucose Testing Strips and Meters

Compatible test strips for blood glucose meters.